Viewing Study NCT00748358

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-05-27 @ 2:52 AM
Study NCT ID: NCT00748358
Status: COMPLETED
Last Update Posted: 2013-09-18
First Post: 2008-09-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostatic Neoplasms View
None Neoplasms, Hormone-Dependent View
None Tumor Markers, Biological View
None Survival Rate View
None Disease-Free Survival View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic prostate carcinoma View
None sunitinib [Substance Name] View
None Clinical Trial, Phase II [Publication Type] View